← All drugs Report issue

odulimomab

mAbexperimental

Clinical trial activity

0 trials · 0 clinical orgs · 0 marketing orgs

Phase 1

0

Phase 2

0

Phase 3

0

Phase 4

0

Mechanism of action

Leukocyte adhesion glycoprotein LFA-1 alphaINHIBITOR
ITGAL inhibitor
- Integrin alpha-L (ITGAL) ↗

Chemistry & pharmacology

Chirality: Single Stereoisomer
Inorganic: No
Polymer: No
Multi-specific: No

Oral

No

Parenteral

No

Topical

No

Sources

ChEMBLCHEMBL2109177 ↗

Also known as

anti-lfa1
anti-lfa-1 mab
anti-lfa-1 monoclonal antibody
odulimomab
odulimomab